Pandemic Medicine : : Why the Global Innovation System Is Broken, and How We Can Fix It / / Kathryn C. Ibata-Arens.

• Superior document: Title is part of eBook package: De Gruyter EBOOK PACKAGE COMPLETE 2021 English
• VerfasserIn: Ibata-Arens, Kathryn C.,
• Place / Publishing House: Boulder : : Lynne Rienner Publishers, , [2022]; ©2021
• Year of Publication: 2022
• Language: English
• Series: Advances in International Political Economy
• Physical Description: 1 online resource (217 p.)
• Other title: Frontmatter --; Contents --; Acknowledgments --; 1 An Innovation Commons: The Global System for New Drug Discovery --; 2 Twilight of the (Big Pharma) Gods: The Rise and Decline of Innovation --; 3 Books of Remedies: China’s Drug (Re)Discovery Politics --; 4 The Turmeric War: India Takes on the World Trade Organization and Big Pharma --; 5 Medicine Gardens: Japan’s Investment in New Drug Discovery --; 6 A Way Forward: Bringing Innovative Solutions to Global Human Health Problems --; Acronyms --; References --; Index --; About the Book
• Format: Mode of access: Internet via World Wide Web.
• ISBN: 9781685851033; 9783110754001; 9783110753776; 9783110754179; 9783110753943; 9783110783520
• DOI: 10.1515/9781685851033
• Access: restricted access
• Hierarchical level: Monograph
• Statement of Responsibility: Kathryn C. Ibata-Arens.

Despite a century of advances in modern medicine, as well as the rapid development of Covid vaccines, the global pharmaceutical industry has largely failed to bring to market drugs that actually cure disease. Why? And looking further . How can government policies stimulate investment in the development of curative drugs? Is there an untapped potential for "natural medicines" in new drug discovery? How have private–public sector partnerships transformed the ways we innovate? To what extent are medicinal plant biodiversity and human health codependent? Addressing this range of increasingly critical questions, Kathryn Ibata-Arens analyzes the rise and decline of the global innovation system for new drug development and proposes a policy framework for fast-tracking the implementation of new discoveries and preparing for future pandemics.